0001209191-17-056389.txt : 20171010
0001209191-17-056389.hdr.sgml : 20171009
20171010150001
ACCESSION NUMBER: 0001209191-17-056389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171005
FILED AS OF DATE: 20171010
DATE AS OF CHANGE: 20171010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILLER LLOYD I III
CENTRAL INDEX KEY: 0000949119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21214
FILM NUMBER: 171130207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Capstone Therapeutics Corp.
CENTRAL INDEX KEY: 0000887151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 860585310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
BUSINESS PHONE: 6022865520
MAIL ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOLOGIC CORP
DATE OF NAME CHANGE: 19940211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-05
0
0000887151
Capstone Therapeutics Corp.
CAPS
0000949119
MILLER LLOYD I III
3300 SOUTH DIXIE HIGHWAY
SUITE 1-365
WEST PALM BEACH
FL
33405
0
0
1
0
Common Stock
2017-10-05
4
S
0
100000
0.06
D
624100
I
By LIMFAM LLC
Common Stock
472792
I
By Milfam II L.P.
Common Stock
90344
I
By Trust D - Lloyd I. Miller
Common Stock
641218
I
By Trust C - Lloyd I. Miller
Common Stock
2914484
I
By LIM III - Trust A-4
Common Stock
2914484
I
By MBM - Trust A-4
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
On September 27, 2017, in accordance with that certain Exercise of Authority of Distribution Adviser of Trust A-4, dated as of August 10, 2017, pursuant to which all securities held by Trust A-4 - Lloyd I. Miller were decanted to two (2) newly formed trusts, the investment adviser to Trust A-4 - Lloyd I. Miller directed the trustee and distribution adviser to distribute fifty percent (50%) of such securities to LIM III - Trust A-4 and fifty percent (50%) of such securities to MBM - Trust A-4. The decanting and distribution of all securities held or formerly held by Trust A-4 - Lloyd I. Miller is in process and final consummation thereof has yet to occur. Such transactions, when consummated, only effect a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was (or will be) exempt from Section 16 of the Securities Exchange Act of 1934 pursuant to Rule 16a-13.
/s/ Paul N. Silverstein
Attorney-in-fact
2017-10-10